Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist – an initial in vitro study
Josef Skopalik,1 Katerina Polakova,2 Marketa Havrdova,2 Ivan Justan,1 Massimiliano Magro,3 David Milde,2 Lucia Knopfova,4 Jan Smarda,4 Helena Polakova,1 Eva Gabrielova,5 Fabio Vianello,2,3 Jaroslav Michalek,1 Radek Zboril21Department of Pharmacology, Masaryk University, Brno, Czech Republic...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-11-01
|
| Series: | International Journal of Nanomedicine |
| Online Access: | http://www.dovepress.com/mesenchymal-stromal-cell-labeling-by-new-uncoated-superparamagnetic-ma-peer-reviewed-article-IJN |
| _version_ | 1818904781473710080 |
|---|---|
| author | Skopalik J Polakova K Havrdova M Justan I Magro M Milde D Knopfova L Smarda J Polakova H Gabrielova E Vianello F Michalek J Zboril R |
| author_facet | Skopalik J Polakova K Havrdova M Justan I Magro M Milde D Knopfova L Smarda J Polakova H Gabrielova E Vianello F Michalek J Zboril R |
| author_sort | Skopalik J |
| collection | DOAJ |
| description | Josef Skopalik,1 Katerina Polakova,2 Marketa Havrdova,2 Ivan Justan,1 Massimiliano Magro,3 David Milde,2 Lucia Knopfova,4 Jan Smarda,4 Helena Polakova,1 Eva Gabrielova,5 Fabio Vianello,2,3 Jaroslav Michalek,1 Radek Zboril21Department of Pharmacology, Masaryk University, Brno, Czech Republic; 2Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry and Analytical Chemistry, Faculty of Science, Palacky University, Olomouc, Czech Republic; 3Department of Comparative Biomedicine and Food Science, University of Padua, Padova, Italy; 4Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic; 5Department of Medical Chemistry and Biochemistry, Faculty of Medicine, Palacky University, Olomouc, Czech RepublicObjective: Cell therapies have emerged as a promising approach in medicine. The basis of each therapy is the injection of 1–100×106 cells with regenerative potential into some part of the body. Mesenchymal stromal cells (MSCs) are the most used cell type in the cell therapy nowadays, but no gold standard for the labeling of the MSCs for magnetic resonance imaging (MRI) is available yet. This work evaluates our newly synthesized uncoated superparamagnetic maghemite nanoparticles (surface-active maghemite nanoparticles – SAMNs) as an MRI contrast intracellular probe usable in a clinical 1.5 T MRI system.Methods: MSCs from rat and human donors were isolated, and then incubated at different concentrations (10–200 µg/mL) of SAMN maghemite nanoparticles for 48 hours. Viability, proliferation, and nanoparticle uptake efficiency were tested (using fluorescence microscopy, xCELLigence analysis, atomic absorption spectroscopy, and advanced microscopy techniques). Migration capacity, cluster of differentiation markers, effect of nanoparticles on long-term viability, contrast properties in MRI, and cocultivation of labeled cells with myocytes were also studied.Results: SAMNs do not affect MSC viability if the concentration does not exceed 100 µg ferumoxide/mL, and this concentration does not alter their cell phenotype and long-term proliferation profile. After 48 hours of incubation, MSCs labeled with SAMNs show more than double the amount of iron per cell compared to Resovist-labeled cells, which correlates well with the better contrast properties of the SAMN cell sample in T2-weighted MRI. SAMN-labeled MSCs display strong adherence and excellent elasticity in a beating myocyte culture for a minimum of 7 days.Conclusion: Detailed in vitro tests and phantom tests on ex vivo tissue show that the new SAMNs are efficient MRI contrast agent probes with exclusive intracellular uptake and high biological safety.Keywords: mesenchymal stromal cells, stem cell tracking, magnetic resonance imaging, superparamagnetic iron oxide nanoparticles, stem cell labelling |
| first_indexed | 2024-12-19T21:12:54Z |
| format | Article |
| id | doaj.art-b73bc7e210924846bc39bad4a563807c |
| institution | Directory Open Access Journal |
| issn | 1178-2013 |
| language | English |
| last_indexed | 2024-12-19T21:12:54Z |
| publishDate | 2014-11-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of Nanomedicine |
| spelling | doaj.art-b73bc7e210924846bc39bad4a563807c2022-12-21T20:05:27ZengDove Medical PressInternational Journal of Nanomedicine1178-20132014-11-012014Issue 15355537219239Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist – an initial in vitro studySkopalik JPolakova KHavrdova MJustan IMagro MMilde DKnopfova LSmarda JPolakova HGabrielova EVianello FMichalek JZboril RJosef Skopalik,1 Katerina Polakova,2 Marketa Havrdova,2 Ivan Justan,1 Massimiliano Magro,3 David Milde,2 Lucia Knopfova,4 Jan Smarda,4 Helena Polakova,1 Eva Gabrielova,5 Fabio Vianello,2,3 Jaroslav Michalek,1 Radek Zboril21Department of Pharmacology, Masaryk University, Brno, Czech Republic; 2Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry and Analytical Chemistry, Faculty of Science, Palacky University, Olomouc, Czech Republic; 3Department of Comparative Biomedicine and Food Science, University of Padua, Padova, Italy; 4Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic; 5Department of Medical Chemistry and Biochemistry, Faculty of Medicine, Palacky University, Olomouc, Czech RepublicObjective: Cell therapies have emerged as a promising approach in medicine. The basis of each therapy is the injection of 1–100×106 cells with regenerative potential into some part of the body. Mesenchymal stromal cells (MSCs) are the most used cell type in the cell therapy nowadays, but no gold standard for the labeling of the MSCs for magnetic resonance imaging (MRI) is available yet. This work evaluates our newly synthesized uncoated superparamagnetic maghemite nanoparticles (surface-active maghemite nanoparticles – SAMNs) as an MRI contrast intracellular probe usable in a clinical 1.5 T MRI system.Methods: MSCs from rat and human donors were isolated, and then incubated at different concentrations (10–200 µg/mL) of SAMN maghemite nanoparticles for 48 hours. Viability, proliferation, and nanoparticle uptake efficiency were tested (using fluorescence microscopy, xCELLigence analysis, atomic absorption spectroscopy, and advanced microscopy techniques). Migration capacity, cluster of differentiation markers, effect of nanoparticles on long-term viability, contrast properties in MRI, and cocultivation of labeled cells with myocytes were also studied.Results: SAMNs do not affect MSC viability if the concentration does not exceed 100 µg ferumoxide/mL, and this concentration does not alter their cell phenotype and long-term proliferation profile. After 48 hours of incubation, MSCs labeled with SAMNs show more than double the amount of iron per cell compared to Resovist-labeled cells, which correlates well with the better contrast properties of the SAMN cell sample in T2-weighted MRI. SAMN-labeled MSCs display strong adherence and excellent elasticity in a beating myocyte culture for a minimum of 7 days.Conclusion: Detailed in vitro tests and phantom tests on ex vivo tissue show that the new SAMNs are efficient MRI contrast agent probes with exclusive intracellular uptake and high biological safety.Keywords: mesenchymal stromal cells, stem cell tracking, magnetic resonance imaging, superparamagnetic iron oxide nanoparticles, stem cell labellinghttp://www.dovepress.com/mesenchymal-stromal-cell-labeling-by-new-uncoated-superparamagnetic-ma-peer-reviewed-article-IJN |
| spellingShingle | Skopalik J Polakova K Havrdova M Justan I Magro M Milde D Knopfova L Smarda J Polakova H Gabrielova E Vianello F Michalek J Zboril R Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist – an initial in vitro study International Journal of Nanomedicine |
| title | Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist – an initial in vitro study |
| title_full | Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist – an initial in vitro study |
| title_fullStr | Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist – an initial in vitro study |
| title_full_unstemmed | Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist – an initial in vitro study |
| title_short | Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist – an initial in vitro study |
| title_sort | mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial resovist ndash an initial in vitro study |
| url | http://www.dovepress.com/mesenchymal-stromal-cell-labeling-by-new-uncoated-superparamagnetic-ma-peer-reviewed-article-IJN |
| work_keys_str_mv | AT skopalikj mesenchymalstromalcelllabelingbynewuncoatedsuperparamagneticmaghemitenanoparticlesincomparisonwithcommercialresovistndashaninitialinvitrostudy AT polakovak mesenchymalstromalcelllabelingbynewuncoatedsuperparamagneticmaghemitenanoparticlesincomparisonwithcommercialresovistndashaninitialinvitrostudy AT havrdovam mesenchymalstromalcelllabelingbynewuncoatedsuperparamagneticmaghemitenanoparticlesincomparisonwithcommercialresovistndashaninitialinvitrostudy AT justani mesenchymalstromalcelllabelingbynewuncoatedsuperparamagneticmaghemitenanoparticlesincomparisonwithcommercialresovistndashaninitialinvitrostudy AT magrom mesenchymalstromalcelllabelingbynewuncoatedsuperparamagneticmaghemitenanoparticlesincomparisonwithcommercialresovistndashaninitialinvitrostudy AT milded mesenchymalstromalcelllabelingbynewuncoatedsuperparamagneticmaghemitenanoparticlesincomparisonwithcommercialresovistndashaninitialinvitrostudy AT knopfoval mesenchymalstromalcelllabelingbynewuncoatedsuperparamagneticmaghemitenanoparticlesincomparisonwithcommercialresovistndashaninitialinvitrostudy AT smardaj mesenchymalstromalcelllabelingbynewuncoatedsuperparamagneticmaghemitenanoparticlesincomparisonwithcommercialresovistndashaninitialinvitrostudy AT polakovah mesenchymalstromalcelllabelingbynewuncoatedsuperparamagneticmaghemitenanoparticlesincomparisonwithcommercialresovistndashaninitialinvitrostudy AT gabrielovae mesenchymalstromalcelllabelingbynewuncoatedsuperparamagneticmaghemitenanoparticlesincomparisonwithcommercialresovistndashaninitialinvitrostudy AT vianellof mesenchymalstromalcelllabelingbynewuncoatedsuperparamagneticmaghemitenanoparticlesincomparisonwithcommercialresovistndashaninitialinvitrostudy AT michalekj mesenchymalstromalcelllabelingbynewuncoatedsuperparamagneticmaghemitenanoparticlesincomparisonwithcommercialresovistndashaninitialinvitrostudy AT zborilr mesenchymalstromalcelllabelingbynewuncoatedsuperparamagneticmaghemitenanoparticlesincomparisonwithcommercialresovistndashaninitialinvitrostudy |